semaglutide injection purpose GLP-1s Some people are overdosing on

The predominant side effects include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting 10-50% of patients depending on the specific product and dose, particularly during dose escalation) Injection site reactions : redness, itching, or discomfort at the subcutaneous injection site Hypoglycaemia : particularly when combined with insulin or sulphonylureas Decreased appetite : an intended therapeutic effect that contributes to weight loss However, some patients do report changes in urinary frequency or patterns

In all trials, the treated groups had similar baseline demographics, including age and gender

Patients with higher levels of Treg cells exhibit poorer clinical outcomes and prognoses in several cancers 4,5

NICE recommends that adults with NAFLD have their fibrosis risk reassessed every three years